The Impact of Telehealth on Health Equity from the Perspective of Large Healthcare Systems during the COVID-19 Pandemic
The fully captioned video and edited transcript will be posted within the next few days.
This COCA Call will be held on Friday, March 27, 2020
During this COCA Call, presenters from Kaiser Permanente and the Veteran’s Health Administration will discuss how telehealth has affected health equity in their patient populations before and during the COVID-19 pandemic. Topics to discuss include challenges and opportunities related to telehealth implementation. Presenters will share strategies to expand access that can reduce disparities and improve culturally responsive care to help achieve health equity within each organization. In addition, presenters from the Centers for Disease Control and Prevention (CDC) will share telehealth strategies that incorporate CDC’s frameworks to Addressing Health Equity in Public Health Practiceexternal icon.
Jeffrey Hall, PhD, MSPH, MA
Chief Health Equity Officer
Centers for Disease Control and Prevention
Edward Lee, MD
Executive Vice President, Information Technology, and Chief Information Officer
The Permanente Federation
Associate Executive Director
The Permanente Medical Group
Matthew Rogers, PA
Clinical Operations Director
Virtual Integrated Multisite Patient Aligned Care Team
Veteran’s Health Administration
Leonie Heyworth, MD, MPH
National Synchronous Telehealth Lead
Office of Connected Care | Telehealth
Veteran’s Health Administration
Due to the high demand we anticipate for this COCA Call, we encourage participants to consider viewing on Facebook. To see the call live, please click on COCA’s Facebook Page.
“This content and conclusions are those of the author and presenter and do not necessarily represent the views of, nor should any endorsements be inferred by, the Centers for Disease Control and Prevention.”
Tuesday, December 8, 2020,
2:00 PM – 3:00 PM ET
US: +1 669 254 5252
or +1 646 828 7666
US: +16692545252,,1600369650# or +16468287666,,1600369650#
Webinar ID: 160 036 9650Add to Calendar
Advanced registration is not required.
Date: Tuesday, December 08, 2020
Time: 2:00 PM – 3:00 PM ET
A few minutes before the webinar begins, please click the link below to join:
Webinar ID: 160 036 9650
Dial-in US: +1 669 254 5252 or +1 646 828 7666
iPhone one-tap: US: +16692545252,,1600369650# or +16468287666,,1600369650#
International numbers available: https://www.zoomgov.com/u/ab3Ojj4XMnexternal icon
At the conclusion of the session, the participant will be able to accomplish the following—
- Describe the impact of telehealth on health equity from the perspective of large healthcare systems.
- Describe lessons learned from healthcare systems’ experiences in using telehealth to address health equity before and during the COVID-19 pandemic.
- List strategies to address health equity in telehealth.
- Discuss CDC’s health equity and telehealth initiatives and recommendations.
COCA Call Objectives
- Cite background information on the topic covered during the presentation.
- Discuss CDC’s role in the topic covered during the presentation.
- Describe the topic’s implications for clinicians.
- Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
- Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.
None at this time
To receive continuing education (CE) for WC2922-120820—Clinician Outreach and Communication Activity (COCA) Calls/Webinars—The Impact of Telehealth on Health Equity from the Perspective of Large Healthcare Systems during the COVID-19 Pandemic, Tuesday, December 8, 2020, please visit TCEO and follow these 9 Simple Steps by Monday, January 11, 2021.
To receive continuing education (CE) for WD2922-120820—Clinician Outreach and Communication Activity (COCA) Calls/Webinars— The Impact of Telehealth on Health Equity from the Perspective of Large Healthcare Systems during the COVID-19 Pandemic, Tuesday, December 08, 2020, (Web on Demand), please visit TCEO and follow these 9 Simple Steps by Thursday, January 12, 2023.
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 1.0 contact hour.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-20-173-L04-Pand enduring JA4008229-0000-20-174-H04-P course category.
This activity has been designated as Knowledge-Based.
In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters.
Planners have reviewed content to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this continuing education activity.
- Physician Assistants
- Health Educators
- Other Clinicians
- Contact Information:firstname.lastname@example.org
- Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communication Branch
- Method of Participation:You may participate in the educational activity by viewing the program information above.